Novavax COVID-19 vaccine could win authorization in India ahead of U.S. – Business Standard
MarsBars/E+ via Getty Images
- Novavax (NVAX +5.7%
) could win the regulatory nod for its COVID-19 shot even without the authorizations from the U.S. and U.K. authorities, Indian-daily Business Standard reported citing a government official. - “Whether or not…
